219 related articles for article (PubMed ID: 30941563)
1. The impact of right ventricular function on prognosis in patients with stage III non-small cell lung cancer after concurrent chemoradiotherapy.
Chen L; Huang J; Wu W; Ta S; Xie X
Int J Cardiovasc Imaging; 2019 Jun; 35(6):1009-1017. PubMed ID: 30941563
[TBL] [Abstract][Full Text] [Related]
2. Correlation between right ventricular T
Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.
Keramida K; Farmakis D; Bingcang J; Sulemane S; Sutherland S; Bingcang RA; Ramachandran K; Tzavara C; Charalampopoulos G; Filippiadis D; Kouris N; Nihoyannopoulos P
Eur J Heart Fail; 2019 Apr; 21(4):529-535. PubMed ID: 30811091
[TBL] [Abstract][Full Text] [Related]
4. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
[TBL] [Abstract][Full Text] [Related]
5. Right ventricular dysfunction in patients with diffuse large B-cell lymphoma undergoing anthracycline-based chemotherapy: a 2D strain and 3D echocardiography study.
Wang B; Yu Y; Zhang Y; Hao X; Yang S; Zhao H; Sun Q; Wang Y
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1311-1319. PubMed ID: 33392873
[TBL] [Abstract][Full Text] [Related]
6. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experience.
Mertsoylu H; Köse F; Sümbül AT; Sedef AM; Doğan Ö; Besen AA; Parlak C; Fındıkçıoğlu A; Muallaoğlu S; Sezer A; Sakallı H; Özyılkan Ö
Med Sci Monit; 2015 Mar; 21():661-6. PubMed ID: 25731741
[TBL] [Abstract][Full Text] [Related]
8. The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy.
Koo TR; Moon SH; Lim YJ; Kim JY; Kim Y; Kim TH; Cho KH; Han JY; Lee YJ; Yun T; Kim HT; Lee JS
Radiat Oncol; 2014 Dec; 9():283. PubMed ID: 25498887
[TBL] [Abstract][Full Text] [Related]
9. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
Dieleman E; van der Woude L; van Os R; van Bockel L; Coremans I; van Es C; De Jaeger K; Knol HP; Kolff W; Koppe F; Pomp J; Reymen B; Schinagl D; Spoelstra F; Tissing-Tan C; van der Voort van Zyp N; van der Wel A; Wijsman R; Dielwart M; Wiegman E; Damhuis R; Belderbos J
Clin Lung Cancer; 2023 Mar; 24(2):130-136. PubMed ID: 36572596
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of right ventricular strain in patients with pulmonary arterial hypertension and relatively preserved functional capacity studied with echocardiography and magnetic resonance.
da Costa Junior AA; Ota-Arakaki JS; Ramos RP; Uellendahl M; Mancuso FJ; Gil MA; Fischer CH; Moises VA; de Camargo Carvalho AC; Campos O
Int J Cardiovasc Imaging; 2017 Jan; 33(1):39-46. PubMed ID: 27566191
[TBL] [Abstract][Full Text] [Related]
11. Right ventricular longitudinal strain predicts acute kidney injury and short-term prognosis in patients with right ventricular myocardial infarction.
Ivey-Miranda JB; Almeida-Gutiérrez E; Borrayo-Sánchez G; Antezana-Castro J; Contreras-Rodríguez A; Posada-Martínez EL; González-Morales E; García-Hernández N; Romero-Zertuche D; Marquez-Gonzalez H; Saturno-Chiu G
Int J Cardiovasc Imaging; 2019 Jan; 35(1):107-116. PubMed ID: 30182321
[TBL] [Abstract][Full Text] [Related]
12. Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
Huang T; Zhang H; Zhao Y; Li Y; Wang G; Zhang Y; Guo D; Ji S; Sun Z
Future Oncol; 2021 Jun; 17(17):2141-2149. PubMed ID: 33635094
[No Abstract] [Full Text] [Related]
13. Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy.
Tokito T; Azuma K; Yamada K; Naito Y; Matsuo N; Ishii H; Natori H; Kinoshita T; Hoshino T
In Vivo; 2019; 33(3):889-895. PubMed ID: 31028213
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of right ventricular free wall strain in pulmonary hypertension patients with pseudo-normalized tricuspid annular plane systolic excursion values.
van Kessel M; Seaton D; Chan J; Yamada A; Kermeen F; Hamilton-Craig C; Butler T; Sabapathy S; Morris N
Int J Cardiovasc Imaging; 2016 Jun; 32(6):905-12. PubMed ID: 26931558
[TBL] [Abstract][Full Text] [Related]
15. Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies.
Zhao J; Xia Y; Kaminski J; Hao Z; Mott F; Campbell J; Sadek R; Kong FM
PLoS One; 2016; 11(6):e0157455. PubMed ID: 27300551
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer.
Katsui K; Ogata T; Watanabe K; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
Acta Med Okayama; 2021 Jun; 75(3):269-277. PubMed ID: 34176930
[TBL] [Abstract][Full Text] [Related]
17. Right ventricular function and mechanics in chemotherapy- and radiotherapy-naïve cancer patients.
Tadic M; Baudisch A; Haßfeld S; Heinzel F; Cuspidi C; Burkhardt F; Escher F; Attanasio P; Pieske B; Genger M
Int J Cardiovasc Imaging; 2018 Oct; 34(10):1581-1587. PubMed ID: 29799062
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
Liu D; Zheng X; Chen J; Liu G; Xu Y; Shen Y; Xie L; Zhao W; Jiang G; Fan M
Lung Cancer; 2015 Sep; 89(3):249-54. PubMed ID: 26118463
[TBL] [Abstract][Full Text] [Related]
19. Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer.
Chang SC; Lai YC; Hung JC; Chang CY
Medicine (Baltimore); 2019 Feb; 98(8):e14463. PubMed ID: 30813149
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer.
Koshy M; Malik R; Mahmood U; Rusthoven CG; Sher DJ
Pract Radiat Oncol; 2015; 5(6):374-82. PubMed ID: 26412340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
